Société Celsus Therapeutics PLC (ADR) Nasdaq
Actions
US15119A2024
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Founder | 79 | 01/09/15 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 19/07/23 |
Miles Nunn
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/15 |
John Neylan
CTO | Chief Tech/Sci/R&D Officer | 70 | 08/11/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 01/06/16 |
Founder | 79 | 01/09/15 | |
Director/Board Member | 61 | 05/07/23 | |
Samir R. Patel
CEO | Chief Executive Officer | 55 | 29/11 |
Director/Board Member | 70 | 23/01/18 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 13 234 315 298 | 13 101 972 145 ( 99,00 %) | 0 | 99,00 % |
Coordonnées société
Akari Therapeutics Plc
22 Boston Wharf Road 7th Floor
02210, Boston
+929 274 7510
http://www.akaritx.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+11,91% | 118 Md | |
+11,60% | 106 Md | |
-4,68% | 24,28 Md | |
-0,82% | 21,96 Md | |
-10,12% | 18,16 Md | |
-42,12% | 16,37 Md | |
-17,47% | 15,56 Md | |
+2,77% | 13,63 Md | |
+34,58% | 12,27 Md |